Mexico - North America Multi Cancer Early Detection Market Size & Outlook
The multi cancer early detection market in Mexico - North America is expected to reach a projected revenue of US$ 17.5 million by 2030. A compound annual growth rate of 10% is expected of Mexico - North America multi cancer early detection market from 2025 to 2030.
- Clinical Diagnostics
- Cancer Diagnostics
- Multi Cancer Early Detection Market Outlook
- Cancer Diagnostics
Revenue, 2024 (US$M)
$9.8
Forecast, 2030 (US$M)
$17.5
CAGR, 2025 - 2030
10.0%
Report Coverage
Mexico
Global Market
Related Markets
Ask Prism AI anything about the multi cancer early detection market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
Mexico multi cancer early detection market highlights
- The Mexico multi cancer early detection market generated a revenue of USD 9.8 million in 2024 and is expected to reach USD 17.5 million by 2030.
- The Mexico market is expected to grow at a CAGR of 10% from 2025 to 2030.
- In terms of segment, gene panel, ldt & others was the largest revenue generating type in 2024.
- Liquid Biopsy is the most lucrative type segment registering the fastest growth during the forecast period.
Multi cancer early detection market data book summary
| Market revenue in 2024 | USD 9.8 million |
| Market revenue in 2030 | USD 17.5 million |
| Growth rate | 10% (CAGR from 2025 to 2030) |
| Largest segment | Gene panel, ldt & others |
| Fastest growing segment | Liquid Biopsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Liquid Biopsy, Gene Panel, LDT & Others |
| Key market players worldwide | Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.9% of the global multi cancer early detection market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. multi cancer early detection market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 845.6 million by 2030.
No credit card required*
Publish Date: Feb 19, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multi Cancer Early Detection Market Scope
Multi Cancer Early Detection Market segmentation & scope
Multi Cancer Early Detection Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Guardant Health Inc | View profile | 1,779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | www.guardanthealth.com |
| Exact Sciences Corp | View profile | 6,600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | www.exactsciences.com |
| Freenome | View profile | 501-1000 | South San Francisco, California, United States, North America | www.freenome.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | www.foundationmedicine.com |
| Burning Rock Biotech Ltd ADR | View profile | 786 | No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, China, People's Republic of, 510005 | www.brbiotech.com |
| AnchorDx | View profile | 51-100 | Guangzhou, Guangdong, China, Asia | www.anchordx.com/ |
| GeneCast | View profile | 1-10 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | genecast.co.kr |
| Elypta | View profile | 11-50 | Stockholm, Stockholms Lan, Sweden, Europe | www.elypta.com/ |
Mexico - North America Multi Cancer Early Detection Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multi Cancer Early Detection Market Outlook will help companies and investors design strategic landscapes.
Gene Panel, Ldt & Others was the largest segment with a revenue share of 101.02% in 2024.
Horizon Databook has segmented the Mexico - North America multi cancer early detection market based on liquid biopsy, gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
- Mexico - North America Multi Cancer Early Detection Market Type Outlook (Revenue, USD Million , 2018-2030)
- Liquid Biopsy
- Gene Panel, LDT & Others
- Mexico - North America Multi Cancer Early Detection Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Hospitals
- Diagnostic Laboratories
- Others
Reasons to subscribe to Multi Cancer Early Detection Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multi Cancer Early Detection Market Outlook databook
- Our clientele includes a mix of Multi Cancer Early Detection Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - North America Multi Cancer Early Detection Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - North America Multi Cancer Early Detection Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Mexico - North America Multi Cancer Early Detection Market, 2018-2030 (US$M)
Mexico multi cancer early detection market statistics, by type, 2018-2030 (US$M)
